AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr | ₹75 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹226 Cr |
Mar2023 | ₹173 Cr |
Mar2022 | ₹172 Cr |
Mar2021 | ₹157 Cr |
Mar2020 | ₹75 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹226 Cr | 30.67 | |
Mar2023 | ₹173 Cr | 0.54 | |
Mar2022 | ₹172 Cr | 9.34 | |
Mar2021 | ₹157 Cr | 110.29 | |
Mar2020 | ₹75 Cr | - |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹62,915.2 Cr | -5.9% | -10% | -12.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -5.9% |
-10% |
-12.1% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses